The FDA recently approved the first agent for treatment of hypoactive ...
This formulation can be used in bioidentical hormone therapy.
Should the ban on using health savings accounts (HSAs) for OTC products be reversed?
Yes, tax-deferred status will improve access to care and reduce costs.
No, changing the law is not necessary.